Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1421
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure
Jennifer Whiteley,Arlene Reisman,Mark Shapiro,JorgeE. Cortes,David Cella
Current Medical Research and Opinion.2016;32(8)1325
2Durability of Kinase-Directed Therapies—A Network Perspective on Response and Resistance
Brion W. Murray,Nichol Miller
Molecular Cancer Therapeutics.2015;14(9)1975
3CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels
Yuming Pan,Jin Lou,Heng Wang,Na An,Huan Chen,Qiaoxia Zhang,Xin Du
Blood Cells, Molecules, and Diseases.2018;73(9)38
Yuming Pan,Jin Lou,Heng Wang,Na An,Huan Chen,Qiaoxia Zhang,Xin Du
Reactions Weekly.2015;1574(1)136
5Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting
Blaise Felix Faye,Nata Dieng,Moussa Seck,Macoura Gadji,Youssou Bamar Gueye,Diariatou Sy,Sokhna Aissatou Toure,Abibatou Sall,Awa Oumar Toure,Tandakha Ndiaye Dieye,Saliou Diop
Annals of Hematology.2016;95(10)1603
6Chronic Myeloid Leukemia in India
Prasanth Ganesan,Lalit Kumar
Journal of Global Oncology.2017;3(1)64
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow